Model predicts that women at the highest risk of breast cancer are no more at risk than the general population if they do not smoke, drink alcohol, use menopausal hormone therapy, and have a low BMI.
The link between lifestyle and colorectal cancer has been increasingly studied, highlighting the potential impact of the standard American diet and inactivity.
Local infiltration of liposomal bupivacaine was associated with reductions in the need for rescue intravenous opioids.
Post-hoc analysis of the PETACC-8 trial tied KRAS and BRAF V600E mutations to shorter overall and disease-free survival in microsatellite stable (MSS) colon cancer.
Survival in stage IV breast cancer is improving, notably so in some patients treated initially with surgery.
Patients with head and neck cancer are three times more likely to commit suicide when compared to the rest of the nation’s population.
Analysis shows a previously unrecognized genetic connection between renal cell carcinoma (RCC) and hematologic malignancies (HM).
ASCO updates Clinical Practice Guidelines for the use of hematopoietic colony-stimulating factors (CSFs).
After a history of over treatment of low-risk prostate cancer, a new study demonstrates an increase in watchful waiting and active surveillance.
Combining a previously established culture medium, researchers were able to create a colon tissue organoid, which could have implications for personalized treatment.
